Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Price / Earnings (ntm)

Arena Pharmaceutical Price / Earnings (ntm) Chart (ARNA)

Arena Pharmaceutical annual/quarterly Price / Earnings (ntm) from 2001 to 2012. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Arena Pharmaceutical Price / Earnings (ntm) for the quarter ending December 12, 2012 was 88.72
Other Valuation Metrics:
  • Arena Pharmaceutical Market Cap for the quarter ending March 03, 2018 was $1,938m a 72.36% increase of 1,402m year over year
  • Arena Pharmaceutical Price / Book for the quarter ending March 03, 2018 was 7.49 a -168.68% decrease of -12.63 year over year
  • Arena Pharmaceutical Enterprise Value for the quarter ending March 03, 2018 was $1,752m a 70.30% increase of 1,232m year over year
View Chart On Koyfin

Quarterly ARNA Price / Earnings (ntm) Data

12/201288.72
06/2001121.96
03/200169.31

Annual ARNA Price / Earnings (ntm) Data

201288.72